DIN 02527618 — VABYSMO 6 MG
VABYSMO is a solution of Faricimab marketed by HOFFMANN-LA ROCHE LIMITED. The full Faricimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02527618
- Brand name
- VABYSMO
- Active ingredient
- Faricimab
- Strength
- 6 MG
- Dosage form
- SOLUTION
- Route
- INTRAVITREAL
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Bispecific anti-VEGF-A / anti-angiopoietin-2 antibody (ophthalmic biologic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Faricimab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02554003 | VABYSMO | 6 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |